Broadwood Capital’s Serina Therapeutics SER Stock Holding History

Broadwood Capital’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,484	Closed	-$104K	–	12
2025 Q4	$104K	Sell	54,484 -28,711	-35%	-$116K	0.01%	12
2025 Q3	$446K	Sell	83,195 -2,024	-2%	-$10.8K	0.03%	12
2025 Q2	$525K	Hold	85,219	–	–	0.03%	13
2025 Q1	$483K	Hold	85,219	–	–	0.04%	8
2024 Q4	$427K	Hold	85,219	–	–	0.03%	7
2024 Q3	$570K	Hold	85,219	–	–	0.04%	7
2024 Q2	$816K	Hold	85,219	–	–	0.06%	7
2024 Q1	$1.15M	Hold	85,219	–	–	0.09%	7
2023 Q4	$1.15M	Hold	85,219	–	–	0.1%	7
2023 Q3	$2.04M	Hold	85,219	–	–	0.18%	7
2023 Q2	$2.68M	Hold	85,219	–	–	0.2%	7
2023 Q1	$1.99M	Hold	85,219	–	–	0.14%	7
2022 Q4	$1.65M	Hold	85,219	–	–	0.14%	7
2022 Q3	$1.68M	Hold	85,219	–	–	0.13%	8
2022 Q2	$1.73M	Hold	85,219	–	–	0.13%	8
2022 Q1	$2.56M	Hold	85,219	–	–	0.18%	7
2021 Q4	$3.27M	Hold	85,219	–	–	0.2%	7
2021 Q3	$2.82M	Hold	85,219	–	–	0.14%	7
2021 Q2	$4.65M	Hold	85,219	–	–	0.21%	7
2021 Q1	$4.86M	Hold	85,219	–	–	0.26%	8
2020 Q4	$4.56M	Hold	85,219	–	–	0.27%	8
2020 Q3	$2.43M	Hold	85,219	–	–	0.19%	7
2020 Q2	$2.84M	Hold	85,219	–	–	0.22%	7
2020 Q1	$2.79M	Hold	85,219	–	–	0.33%	7
2019 Q4	$5.46M	Hold	85,219	–	–	0.63%	7
2019 Q3	$5.87M	Hold	85,219	–	–	0.82%	7
2019 Q2	$11M	Hold	85,219	–	–	1.38%	7
2019 Q1	$12.1M	Hold	85,219	–	–	1.49%	7
2018 Q4	$8.96M	Buy	+85,219	New	+$10.8M	1.26%	7

Other funds holding SER

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

AWE

Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Broadwood Capital's SER Position: Q1 2026 in Review

Broadwood Capital sold out of Serina Therapeutics (SER) in Q1 2026, closing a stake of 54,484 shares — an estimated $104K sold.

Broadwood Capital first reported a position in SER in Q4 2018 and held it in 29 quarters. The position peaked at $12.1M in Q1 2019. 25 funds tracked by Wall St. Rank hold SER as of Q1 2026.

Broadwood Capital reported no remaining Serina Therapeutics position as of Q1 2026 after selling out during the quarter.
Broadwood Capital sold 54,484 Serina Therapeutics shares in Q1 2026, an estimated $104K.
Broadwood Capital first reported a position in Serina Therapeutics in Q4 2018 and held it in 29 quarters.
Broadwood Capital's Serina Therapeutics position peaked at $12.1M in Q1 2019.
25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.

Based on Broadwood Capital's 13F filing for Q1 2026, filed 15 May 2026.